Fortress Biotech, Inc.

Total Valuation

Fortress Biotech, Inc. carries a market capitalization of 62.37M, placing it among publicly traded companies globally. Its enterprise value stands at 620,696.72, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Fortress Biotech, Inc. currently has 33.31M shares outstanding.

Valuation Ratios

Fortress Biotech, Inc. trades at a trailing price-to-earnings ratio of 0.89. The price-to-sales ratio is 1.35, and the price-to-book ratio stands at 0.62.

Enterprise Valuation

Financial Position

Fortress Biotech, Inc. maintains a current ratio of 3.96, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 25.87, indicating elevated leverage, while an interest coverage ratio of -3.46 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Fortress Biotech, Inc. posts a return on equity of 99.36 and a return on invested capital of -15.27.

Taxes

Over the trailing twelve months, Fortress Biotech, Inc. has paid 4.66M in income taxes, reflecting an effective tax rate of 3.20.

Stock Price Statistics

Fortress Biotech, Inc.'s stock has declined approximately -32.24638% over the past 52 weeks. The 50-day moving average sits at 2.47, while the 200-day moving average is 2.88.

Income Statement

Over the trailing twelve months, Fortress Biotech, Inc. generated 68.47M in revenue and converted that into 111.82M in net income, yielding earnings per share of 4.10. EBITDA reached -24.75M, while operating income came in at -29.34M.

Balance Sheet

Fortress Biotech, Inc. holds 196.58M in cash and equivalents against 53.32M in total debt, resulting in a net debt position of -156.97M. Total book value stands at 164.14M, with working capital of 183.49M providing operational flexibility.

Cash Flow

Fortress Biotech, Inc. produced 125.92M in operating cash flow over the past twelve months.

Margins

Fortress Biotech, Inc. operates with a gross margin of 65.59, reflecting its pricing power and cost economics. The operating margin of -42.86 and net profit margin of 163.32 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -4.92 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Fortress Biotech, Inc.'s most recent stock split took place on October 10, 2023 with a 15:1 split ratio.

Scores

Fortress Biotech, Inc. posts an Altman Z-Score of -1.79, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.